Literature DB >> 3464209

Secondary fibrositis.

P K Hench.   

Abstract

Fibrositis is considered primary when there is no associated underlying disorder, and secondary when it occurs in patients with underlying rheumatic or other organic disease. Since fibrositis has become better defined, the list of underlying disorders has grown, and its identification requires careful diagnostic study. The differentiation of primary and secondary fibrositis has therapeutic implications. Secondary fibrositis should respond to treatment of the underlying disorder, whereas the primary syndrome may require additional management directed to the musculoskeletal pain and sleep and emotional disturbances commonly recognized as major manifestations of this syndrome.

Entities:  

Mesh:

Year:  1986        PMID: 3464209     DOI: 10.1016/0002-9343(86)90877-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Top down or bottom up? An observational investigation of improvement in fibromyalgia symptoms following hip and knee replacement.

Authors:  Andrew Schrepf; Stephanie Moser; Steven E Harte; Neil Basu; Chelsea Kaplan; Ellen Kolarik; Alexander Tsodikov; Chad M Brummett; Daniel J Clauw
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

Review 2.  Critical role of nociceptor plasticity in chronic pain.

Authors:  David B Reichling; Jon D Levine
Journal:  Trends Neurosci       Date:  2009-09-24       Impact factor: 13.837

3.  Ultrasound evidence of altered lumbar connective tissue structure in human subjects with chronic low back pain.

Authors:  Helene M Langevin; Debbie Stevens-Tuttle; James R Fox; Gary J Badger; Nicole A Bouffard; Martin H Krag; Junru Wu; Sharon M Henry
Journal:  BMC Musculoskelet Disord       Date:  2009-12-03       Impact factor: 2.362

4.  Comorbidity of Fibromyalgia in Primary Knee Osteoarthritis: Potential Impact on Functional Status and Quality of Life.

Authors:  Marwa Yahia Mahgoub; Basant Mohamed Elnady; Haytham Sayed Abdelkader; Raghdaa Abdelkhaleq Abdelhalem; Waleed Ahmed Hassan
Journal:  Open Access Rheumatol       Date:  2020-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.